89 results on '"Tirupathi S"'
Search Results
2. Multilevel and local time-stepping discontinuous Galerkin methods for magma dynamics
- Author
-
Tirupathi, S., Hesthaven, J. S., Liang, Y., and Parmentier, M.
- Published
- 2015
- Full Text
- View/download PDF
3. Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic: P19
- Author
-
Healy, E. G., Carr, A. S., Tirupathi, S., Pang, K., Herron, B. M., Cardwell, C., Palace, J., Beeson, D., and McConville, J.
- Published
- 2014
4. Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C
- Author
-
Pelletier, F. Perrier, S. Cayami, F.K. Mirchi, A. Saikali, S. Tran, L.T. Ulrick, N. Guerrero, K. Rampakakis, E. Van Spaendonk, R.M.L. Naidu, S. Pohl, D. Gibson, W.T. Demos, M. Goizet, C. Tejera-Martin, I. Potic, A. Fogel, B.L. Brais, B. Sylvain, M. Sébire, G. Lourenço, C.M. Bonkowsky, J.L. Catsman-Berrevoets, C. Pinto, P.S. Tirupathi, S. Strømme, P. De Grauw, T. Gieruszczak-Bialek, D. Krägeloh-Mann, I. Mierzewska, H. Philippi, H. Rankin, J. Atik, T. Banwell, B. Benko, W.S. Blaschek, A. Bley, A. Boltshauser, E. Bratkovic, D. Brozova, K. Cimas, I. Clough, C. Corenblum, B. Dinopoulos, A. Dolan, G. Faletra, F. Fernandez, R. Fletcher, J. Garcia Garcia, M.E. Gasparini, P. Gburek-Augustat, J. Gonzalez Moron, D. Hamati, A. Harting, I. Hertzberg, C. Hill, A. Hobson, G.M. Innes, A.M. Kauffman, M. Kirwin, S.M. Kluger, G. Kolditz, P. Kotzaeridou, U. La Piana, R. Liston, E. McClintock, W. McEntagart, M. McKenzie, F. Melançon, S. Misbahuddin, A. Suri, M. Monton, F.I. Moutton, S. Murphy, R.P.J. Nickel, M. Onay, H. Orcesi, S. Özklnay, F. Patzer, S. Pedro, H. Pekic, S. Pineda Marfa, M. Pizzino, A. Plecko, B. Poll-The, B.T. Popovic, V. Rating, D. Rioux, M.-F. Rodriguez Espinosa, N. Ronan, A. Ostergaard, J.R. Rossignol, E. Sanchez-Carpintero, R. Schossig, A. Senbil, N. Sønderberg Roos, L.K. Stevens, C.A. Synofzik, M. Sztriha, L. Tibussek, D. Timmann, D. Tonduti, D. Van De Warrenburg, B.P. Vázquez-López, M. Venkateswaran, S. Wasling, P. Wassmer, E. Webster, R.I. Wiegand, G. Yoon, G. Rotteveel, J. Schiffmann, R. Van Der Knaap, M.S. Vanderver, A. Martos-Moreno, G.Á. Polychronakos, C. Wolf, N.I. Bernard, G.
- Abstract
Context: 4H or POLR3-related leukodystrophy is an autosomal recessive disorder typically characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism, caused by biallelic pathogenic variants in POLR3A, POLR3B, POLR1C, and POLR3K. The endocrine and growth abnormalities associated with this disorder have not been thoroughly investigated to date. Objective: To systematically characterize endocrine abnormalities of patients with 4H leukodystrophy. Design: An international cross-sectional study was performed on 150 patients with genetically confirmed 4H leukodystrophy between 2015 and 2016. Endocrine and growth abnormalities were evaluated, and neurological and other non-neurological features were reviewed. Potential genotype/phenotype associations were also investigated. Setting: This was a multicenter retrospective study using information collected from 3 predominant centers. Patients: A total of 150 patients with 4H leukodystrophy and pathogenic variants in POLR3A, POLR3B, or POLR1C were included. Main Outcome Measures: Variables used to evaluate endocrine and growth abnormalities included pubertal history, hormone levels (estradiol, testosterone, stimulated LH and FSH, stimulated GH, IGF-I, prolactin, ACTH, cortisol, TSH, and T4), and height and head circumference charts. Results: The most common endocrine abnormalities were delayed puberty (57/74; 77% overall, 64% in males, 89% in females) and short stature (57/93; 61%), when evaluated according to physician assessment. Abnormal thyroid function was reported in 22% (13/59) of patients. Conclusions: Our results confirm pubertal abnormalities and short stature are the most common endocrine features seen in 4H leukodystrophy. However, we noted that endocrine abnormalities are typically underinvestigated in this patient population. A prospective study is required to formulate evidence-based recommendations for management of the endocrine manifestations of this disorder. © 2020 The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society.
- Published
- 2021
5. Making sense of missense variants in TTN-related congenital myopathies
- Author
-
Rees, M., Nikoopour, R., Fukuzawa, A., Kho, A.L., Fernandez-Garcia, M.A., Wraige, E., Bodi, I., Deshpande, C., Özdemir, Ö., Daimagüler, H.S., Pfuhl, M., Holt, M., Brandmeier, B., Grover, S., Fluss, J., Longman, C., Farrugia, M.E., Matthews, E., Hanna, M., Muntoni, F., Sarkozy, A., Phadke, R., Quinlivan, R., Oates, E.C., Schröder, R., Thiel, C, Reimann, J., Voermans, N.C., Erasmus, C.E., Kamsteeg, E.J., Konersman, C., Grosmann, C., McKee, S., Tirupathi, S., Moore, S.A., Wilichowski, E., Hobbiebrunken, E., Dekomien, G., Richard, I., Bergh, P., Domínguez-González, C., Cirak, S., Ferreiro, A., Jungbluth, H., Gautel, M., Rees, M., Nikoopour, R., Fukuzawa, A., Kho, A.L., Fernandez-Garcia, M.A., Wraige, E., Bodi, I., Deshpande, C., Özdemir, Ö., Daimagüler, H.S., Pfuhl, M., Holt, M., Brandmeier, B., Grover, S., Fluss, J., Longman, C., Farrugia, M.E., Matthews, E., Hanna, M., Muntoni, F., Sarkozy, A., Phadke, R., Quinlivan, R., Oates, E.C., Schröder, R., Thiel, C, Reimann, J., Voermans, N.C., Erasmus, C.E., Kamsteeg, E.J., Konersman, C., Grosmann, C., McKee, S., Tirupathi, S., Moore, S.A., Wilichowski, E., Hobbiebrunken, E., Dekomien, G., Richard, I., Bergh, P., Domínguez-González, C., Cirak, S., Ferreiro, A., Jungbluth, H., and Gautel, M.
- Abstract
Contains fulltext : 231686.pdf (Publisher’s version ) (Open Access), Mutations in the sarcomeric protein titin, encoded by TTN, are emerging as a common cause of myopathies. The diagnosis of a TTN-related myopathy is, however, often not straightforward due to clinico-pathological overlap with other myopathies and the prevalence of TTN variants in control populations. Here, we present a combined clinico-pathological, genetic and biophysical approach to the diagnosis of TTN-related myopathies and the pathogenicity ascertainment of TTN missense variants. We identified 30 patients with a primary TTN-related congenital myopathy (CM) and two truncating variants, or one truncating and one missense TTN variant, or homozygous for one TTN missense variant. We found that TTN-related myopathies show considerable overlap with other myopathies but are strongly suggested by a combination of certain clinico-pathological features. Presentation was typically at birth with the clinical course characterized by variable progression of weakness, contractures, scoliosis and respiratory symptoms but sparing of extraocular muscles. Cardiac involvement depended on the variant position. Our biophysical analyses demonstrated that missense mutations associated with CMs are strongly destabilizing and exert their effect when expressed on a truncating background or in homozygosity. We hypothesise that destabilizing TTN missense mutations phenocopy truncating variants and are a key pathogenic feature of recessive titinopathies that might be amenable to therapeutic intervention.
- Published
- 2021
6. Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C
- Author
-
Pelletier, F., Perrier, S., Cayami, F.K., Mirchi, A., Saikali, S., Tran, L.T., Ulrick, N., Guerrero, K., Rampakakis, E., Spaendonk, R.M.L. van, Naidu, S., Pohl, D., Gibson, W.T., Demos, M., Goizet, C., Tejera-Martin, I., Potic, A., Fogel, B.L., Brais, B., Sylvain, M., Sébire, G., Lourenço, C.M., Bonkowsky, J.L., Catsman-Berrevoets, C., Pinto, P.S., Tirupathi, S., Strømme, P., Grauw, T. de, Gieruszczak-Bialek, D., Krägeloh-Mann, I., Mierzewska, H., Philippi, H., Rankin, J., Atik, T., Banwell, B., Benko, W.S., Blaschek, A., Bley, A., Boltshauser, E., Bratkovic, D., Brozova, K., Cimas, I., Clough, C., Corenblum, B., Dinopoulos, A., Dolan, G., Faletra, F., Fernandez, R., Fletcher, J., Garcia, M.E., Gasparini, P., Gburek-Augustat, J., Moron, D. Gonzalez, Hamati, A., Harting, I., Hertzberg, C., Hill, A., Hobson, G.M., Innes, A. Micheil, Kauffman, M., Kirwin, S.M., Kluger, G., Kolditz, P., Kotzaeridou, U., Piana, R., Liston, E., McClintock, W., McEntagart, M., McKenzie, F., Melançon, S., Misbahuddin, A., Suri, M., Monton, F.I., Moutton, S., Murphy, R.P.J., Nickel, M., Onay, H., Orcesi, S., Özkınay, F., Patzer, S., Pedro, H., Pekic, S., Marfa, M. Pineda, Pizzino, A., Plecko, B., Poll-The, B.T., Popovic, V., Rating, D., Rioux, M.F., Espinosa, N. Rodriguez, Ronan, A., Ostergaard, J.R., Rossignol, E., Sanchez-Carpintero, R., Schossig, A., Senbil, N., Roos, L.K. Sønderberg, Stevens, C.A., Synofzik, M., Sztriha, L., et al., Warrenburg, B.P.C. van de, Wolf, N.I., Bernard, G., Pelletier, F., Perrier, S., Cayami, F.K., Mirchi, A., Saikali, S., Tran, L.T., Ulrick, N., Guerrero, K., Rampakakis, E., Spaendonk, R.M.L. van, Naidu, S., Pohl, D., Gibson, W.T., Demos, M., Goizet, C., Tejera-Martin, I., Potic, A., Fogel, B.L., Brais, B., Sylvain, M., Sébire, G., Lourenço, C.M., Bonkowsky, J.L., Catsman-Berrevoets, C., Pinto, P.S., Tirupathi, S., Strømme, P., Grauw, T. de, Gieruszczak-Bialek, D., Krägeloh-Mann, I., Mierzewska, H., Philippi, H., Rankin, J., Atik, T., Banwell, B., Benko, W.S., Blaschek, A., Bley, A., Boltshauser, E., Bratkovic, D., Brozova, K., Cimas, I., Clough, C., Corenblum, B., Dinopoulos, A., Dolan, G., Faletra, F., Fernandez, R., Fletcher, J., Garcia, M.E., Gasparini, P., Gburek-Augustat, J., Moron, D. Gonzalez, Hamati, A., Harting, I., Hertzberg, C., Hill, A., Hobson, G.M., Innes, A. Micheil, Kauffman, M., Kirwin, S.M., Kluger, G., Kolditz, P., Kotzaeridou, U., Piana, R., Liston, E., McClintock, W., McEntagart, M., McKenzie, F., Melançon, S., Misbahuddin, A., Suri, M., Monton, F.I., Moutton, S., Murphy, R.P.J., Nickel, M., Onay, H., Orcesi, S., Özkınay, F., Patzer, S., Pedro, H., Pekic, S., Marfa, M. Pineda, Pizzino, A., Plecko, B., Poll-The, B.T., Popovic, V., Rating, D., Rioux, M.F., Espinosa, N. Rodriguez, Ronan, A., Ostergaard, J.R., Rossignol, E., Sanchez-Carpintero, R., Schossig, A., Senbil, N., Roos, L.K. Sønderberg, Stevens, C.A., Synofzik, M., Sztriha, L., et al., Warrenburg, B.P.C. van de, Wolf, N.I., and Bernard, G.
- Abstract
Contains fulltext : 235629.pdf (Publisher’s version ) (Open Access), CONTEXT: 4H or POLR3-related leukodystrophy is an autosomal recessive disorder typically characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism, caused by biallelic pathogenic variants in POLR3A, POLR3B, POLR1C, and POLR3K. The endocrine and growth abnormalities associated with this disorder have not been thoroughly investigated to date. OBJECTIVE: To systematically characterize endocrine abnormalities of patients with 4H leukodystrophy. DESIGN: An international cross-sectional study was performed on 150 patients with genetically confirmed 4H leukodystrophy between 2015 and 2016. Endocrine and growth abnormalities were evaluated, and neurological and other non-neurological features were reviewed. Potential genotype/phenotype associations were also investigated. SETTING: This was a multicenter retrospective study using information collected from 3 predominant centers. PATIENTS: A total of 150 patients with 4H leukodystrophy and pathogenic variants in POLR3A, POLR3B, or POLR1C were included. MAIN OUTCOME MEASURES: Variables used to evaluate endocrine and growth abnormalities included pubertal history, hormone levels (estradiol, testosterone, stimulated LH and FSH, stimulated GH, IGF-I, prolactin, ACTH, cortisol, TSH, and T4), and height and head circumference charts. RESULTS: The most common endocrine abnormalities were delayed puberty (57/74; 77% overall, 64% in males, 89% in females) and short stature (57/93; 61%), when evaluated according to physician assessment. Abnormal thyroid function was reported in 22% (13/59) of patients. CONCLUSIONS: Our results confirm pubertal abnormalities and short stature are the most common endocrine features seen in 4H leukodystrophy. However, we noted that endocrine abnormalities are typically underinvestigated in this patient population. A prospective study is required to formulate evidence-based recommendations for management of the endocrine manifestations of this disorder.
- Published
- 2021
7. Ictal apnoea in infancy: T040
- Author
-
CASSIDY, D, COURTNEY, J, HANRAHAN, J D, ANDERSON, C, OʼKANE, K, and TIRUPATHI, S
- Published
- 2012
8. Use of zonisamide in children less than 1 year of age: T031
- Author
-
CROWE, B, FEENEY, M, ROBINSON, N, HANRAHAN, D, TIRUPATHI, S, and PEAKE, D
- Published
- 2012
9. Comparative cariostatic efficacy of a novel Nano-silver fluoride varnish with 38% silver diamine fluoride varnish a double-blind randomized clinical trial
- Author
-
Tirupathi, S, primary, SVSG, N, additional, Rajasekhar, S, additional, and Nuvvula, S, additional
- Published
- 2019
- Full Text
- View/download PDF
10. A Study on Groundwater Recharge and Fluctuation of Vadrapalem Village in Madakasira Mandal of Andhrapradesh
- Author
-
Laxman, B., primary, Ramana, M.V., additional, and Tirupathi, S., additional
- Published
- 2018
- Full Text
- View/download PDF
11. The use of nusinersen in the “real world”: the UK and Ireland experience with the expanded access program (EAP)
- Author
-
Scoto, M., primary, Manzur, A., additional, Main, M., additional, Munot, P., additional, Tillmann, R., additional, Marini Bettolo, C., additional, Mayhew, A., additional, Muni-Lofra, R., additional, White, K., additional, Baxter, P., additional, Tirupathi, S., additional, Douglas, I., additional, Douglas, M., additional, Macauley, S., additional, Childs, A.-M., additional, O’Rourke, D., additional, Hartley, L., additional, Hughes, I., additional, McCullagh, G., additional, Spinty, S., additional, Madhu, R., additional, Gregson, S., additional, Gowda, V., additional, Wraige, E., additional, Horrocks, I., additional, Brunklaus, A., additional, Di Marco, M., additional, Dunne, J., additional, Brown, S., additional, Mochrie, R., additional, Illingworth, M., additional, Krishnakumar, D., additional, Kirkpatrick, M., additional, Ramdas, S., additional, Vijayakumar, K., additional, Selby, V., additional, Kulshrestha, R., additional, Willis, T., additional, Straub, V., additional, and Muntoni, F., additional
- Published
- 2018
- Full Text
- View/download PDF
12. S02. Delineation of a recognisable phenotype of interstitial deletion 3 (q22.3q25.1) in a case with previously unreported truncus arteriosus
- Author
-
Stewart, Fiona J, Wraith, J Edmond, Tylee, Karen, Cooper, Alan, Rea, Gillian, McCullough, Simon, McNerlan, Susan S, Craig, Brian, Morrison, Patrick J, Meaney, Karen, O'hIci, Bronagh, Lynch, Sally Ann, Barton, David E, Jeffers, Lisa, Fitzsimons, Donna, McCaughan, Eilis, Morrison, Patrick, Heggarty, SV, Wright, W, Stewart, FJ, Hart, PJ, McKeown, P, Graham, CA, Dagdan, Elif, Morris, Derek W, Hill, Matthew, Rothermundt, Matthias, Kästner, Florian, Hohoff, Christa, Deckert, Jürgen, von Eiff, Christof, Krakowitzky, Petra, Hargreaves, April, Rose, Emma, Corvin, Aiden P, Donohoe, Gary, Gill, Michael, McKeon, Patrick, Roche, Siobhan, Quinn, Emma M, Kenny, Elaine M, Cormican, Paul, Gates, Amy S, McCarthy, Nina, Vangjeli, Ciara, Cavalleri, Gianpiero, Shianna, Kevin, Delanty, Norman, O'Brien, Eoin, Harvey, Brian, Stanton, Alice, Heron, Elizabeth A, Gilks, William P, Surendran, Praveen, Shields, Denis, Minguzzi, S, Molloy, A, Kirke, P, Mills, J, Scott, J, Troendle, J, Pangilinan, F, Brody, L, Parle-McDermott, A, Carey, A, Lynch, S A, Hegarty, A-M, Betts, D R, Beckett, A, Smith, G, McCullough, S, Humphreys, M, Dabir, T, McKee, S, Magee, A, Stewatr, F, McConnell, V, Simpson, DA, Harwood, L, Clark, GR, Alexander, S, Silvestri, G, Willoughby, C, Donnelly, Deirdre E, McConnell, Vivienne, Paterson, Anne, Patrick, J Morrison, Turnpenny, Peter, McConnell, Vivienne PM, Beattie, ED, Møller, Lisbeth Birk, Hughes, Joanne, Rea, G, Tirupathi, S, Herron, B, Healy, E, Woods, P, Beattie, D, Stewart, F, Crawford, H, McDaid, J, Hegarty, AM, Turner, J, Clarke, G, Morris, T, O'hIci, B, Meaney, K, Green, A, Betts, DR, Jones, J, McCullough, SJ, Stewart, F J, Bradley, Lisa, Willoughby, Colin, Murtagh, Katherine, Ekstrom, L, Mullarkey, M, Logan, Amy, McGrattan, Peter, Marron, G, Harding-Lester, Siobhan, Bradley, Aoife, Wright, WT, Nicholls, DP, McNerlan, SE, McGrattan, P, Heggarty, S, Erwin, P, Dabir, Tabib, Stewart, Fiona, Grier, David G, Smith, Geoff, Magee, Alex, Hardy, Rachel, Bhupeshkumar, V, Kumar, Vijaya, Naik, Sudhir, Sadhnani, Subash, Stanton, Alice V, Muszynska, D, Dash, DP, Lechner, J, O'Prey, D, Frazer, D, Moore, J, Jackson, J, Hughes, AE, Willoughby, CE, Vanc, DR, Maxwel, AP, McKnigh, AJ, Skehan, EB, Abdulrahim, MMA, Parfrey, NA, Hand, CK, Habibi, R, Shiva, M, Mokhtari, P, Gourabi, H, Casey, J, Conroy, J, Regan, R, Shah, N, Lynch, SA, Ennis, S, Frazer, DG, Simpson, DAC, Paro, Simona, McGurk, Leeanne, Raja, Aruna, Sun, Hui, Noble, Brendon, Heath, Paul, Ince, Paul, Shaw, Pamela, Brindle, James, O'Connell, Mary, Keegan, Liam, Carroll, N, MacCooey, A, Sweeney, MR, Boilson, A, Scott, JM, Staines, A, Kelleher, C, Daly, L, Bailey, SW, Alverson, PB, and Ayling, JE
- Subjects
Poster Presentations ,Abstracts ,Spoken Paper ,Spoken Papers ,Abstract - Published
- 2010
13. MND03 - The use of nusinersen in the “real world”: the UK and Ireland experience with the expanded access program (EAP)
- Author
-
Scoto, M., Manzur, A., Main, M., Munot, P., Tillmann, R., Marini Bettolo, C., Mayhew, A., Muni-Lofra, R., White, K., Baxter, P., Tirupathi, S., Douglas, I., Douglas, M., Macauley, S., Childs, A.-M., O’Rourke, D., Hartley, L., Hughes, I., McCullagh, G., Spinty, S., Madhu, R., Gregson, S., Gowda, V., Wraige, E., Horrocks, I., Brunklaus, A., Di Marco, M., Dunne, J., Brown, S., Mochrie, R., Illingworth, M., Krishnakumar, D., Kirkpatrick, M., Ramdas, S., Vijayakumar, K., Selby, V., Kulshrestha, R., Willis, T., Straub, V., and Muntoni, F.
- Published
- 2018
- Full Text
- View/download PDF
14. PP04.3 – 2650: Varicella angiopathy: The current challenges of management
- Author
-
Flanagan, C., primary, Christie, S., additional, McCaughey, C., additional, and Tirupathi, S., additional
- Published
- 2015
- Full Text
- View/download PDF
15. Adherence to antiepileptic medicines in children: A multiple-methods assessment involving dried blood spot sampling.
- Author
-
Peake D., Hawwa A.F., Millership J.S., Collier P.S., Ho P., Tan M.L., Tirupathi S., McElnay J.C., Craig J., Shepherd C., Bailie N., Bothwell J., Shah N.M., Peake D., Hawwa A.F., Millership J.S., Collier P.S., Ho P., Tan M.L., Tirupathi S., McElnay J.C., Craig J., Shepherd C., Bailie N., Bothwell J., and Shah N.M.
- Abstract
Summary Purpose To evaluate adherence to prescribed antiepileptic drugs (AEDs) in children with epilepsy using a combination of adherence-assessment methods. Methods A total of 100 children with epilepsy (<=17 years old) were recruited. Medication adherence was determined via parental and child self-reporting (>=9 years old), medication refill data from general practitioner (GP) prescribing records, and via AED concentrations in dried blood spot (DBS) samples obtained from children at the clinic and via self- or parental-led sampling in children's own homes. The latter were assessed using population pharmacokinetic modeling. Patients were deemed nonadherent if any of these measures were indicative of nonadherence with the prescribed treatment. In addition, beliefs about medicines, parental confidence in seizure management, and the presence of depressed mood in parents were evaluated to examine their association with nonadherence in the participating children. Key Findings The overall rate of nonadherence in children with epilepsy was 33%. Logistic regression analysis indicated that children with generalized epilepsy (vs. focal epilepsy) were more likely (odds ratio [OR] 4.7, 95% confidence interval [CI] 1.37-15.81) to be classified as nonadherent as were children whose parents have depressed mood (OR 3.6, 95% CI 1.16-11.41). Significance This is the first study to apply the novel methodology of determining adherence via AED concentrations in clinic and home DBS samples. The present findings show that the latter, with further development, could be a useful approach to adherence assessment when combined with other measures including parent and child self-reporting. Seizure type and parental depressed mood were strongly predictive of nonadherence. © Wiley Periodicals, Inc. © 2013 International League Against Epilepsy.
- Published
- 2013
16. O27 – 2082 Anti-myelin oligodendrocyte glycoprotein antibody positivity in children with demyelinating episodes
- Author
-
Hughes, SE, primary, James, S, additional, Flynn, P, additional, Smyth, G, additional, McKinstry, S, additional, Rennie, I, additional, Hanrahan, D, additional, Peake, D, additional, and Tirupathi, S, additional
- Published
- 2013
- Full Text
- View/download PDF
17. Acute demyelinating events with rhombencephalitis: A high-risk subgroup in children
- Author
-
Tirupathi, S., Lynch, N., Phelan, E., Mc Menamin, J., and Webb, D.
- Published
- 2008
- Full Text
- View/download PDF
18. P21.12 CNS infection via cutaneous to neural route. Report of two cases.
- Author
-
Groves, H.E., primary, Loughran, C., additional, Hanrahan, D., additional, Tirupathi, S., additional, Christie, S., additional, and McConnell, R., additional
- Published
- 2011
- Full Text
- View/download PDF
19. 661 Fast Channel Syndrome: Presentation, Diagnosis and Management in An Infant
- Author
-
Mallappa, A, primary, Tirupathi, S, additional, Boyd, J, additional, B'Connor, O, additional, and Illingworth, M, additional
- Published
- 2010
- Full Text
- View/download PDF
20. Design and operation of a supersonic flow cavity for a non-self-sustained electric discharge pumped oxygen–iodine laser
- Author
-
Hicks, A, primary, Tirupathi, S, additional, Jiang, N, additional, Utkin, Yu, additional, Lempert, W R, additional, Rich, J W, additional, and Adamovich, I V, additional
- Published
- 2007
- Full Text
- View/download PDF
21. Gain measurements in a non-self-sustained electric discharge pumped oxygen-iodine laser cavity
- Author
-
Hicks, A., primary, Fredrickson, K., additional, Tirupathi, S., additional, Utkin, Y. G., additional, Lempert, W. R., additional, Rich, J. W., additional, Adamovich, I. V., additional, Galbally-Kinney, K. L., additional, Kessler, W. J., additional, Rawlins, W. T., additional, Mulhall, P. A., additional, and Davis, S. J., additional
- Published
- 2006
- Full Text
- View/download PDF
22. Coats' Plus: A Progressive Familial Syndrome of Bilateral Coats' Disease, Characteristic Cerebral Calcification, Leukoencephalopathy, Slow Pre- and Post-Natal Linear Growth and Defects of Bone Marrow and Integument
- Author
-
Crow, Y., primary, McMenamin, J., additional, Haenggeli, C., additional, Hadley, D., additional, Tirupathi, S., additional, Treacy, E., additional, Zuberi, S., additional, Browne, B., additional, Tolmie, J., additional, and Stephenson, J., additional
- Published
- 2004
- Full Text
- View/download PDF
23. Gain measurements in a non-self-sustained electric discharge pumped oxygen-iodine laser cavity.
- Author
-
Hicks, A., Fredrickson, K., Tirupathi, S., Utkin, Y. G., Lempert, W. R., Rich, J. W., Adamovich, I. V., Galbally-Kinney, K. L., Kessler, W. J., Rawlins, W. T., Mulhall, P. A., and Davis, S. J.
- Published
- 2006
- Full Text
- View/download PDF
24. Organogenesis from in vitro-derived leaf and internode explants of Hoya wightii ssp. palniensis -a vulnerable species of Western Ghats
- Author
-
Subbaiah Revathi Lakshmi, Jambarapu Herald Franklin Benjamin, Tirupathi Senthil Kumar, Garimella Venkata Suryanarayana Murthy, and Mandali Venkateswara Rao
- Subjects
In vitro explants ,organogenesis ,Hoya wightii ssp. Palniensis ,vulnerable plant ,growth regulators ,Biotechnology ,TP248.13-248.65 - Abstract
An efficient system was developed for indirect plant regeneration from in vitro-derived leaf and internode explants of Hoya wightii ssp. palniensis. Maximum percentage of the organogenic callus was obtained on MS medium supplemented with NAA (1.0 mg/l) and 2,4-D (2.0 mg/l). The best shoot bud induction was observed on MS medium with BA (1.0 mg/l) +IBA (0.5 mg/l). The coconut water (15%) was better, resulting in a differentiation of the shoot initials in to well-developed shoots. The elongated shoots (› 3cm long) were rooted on a full strength MS basal medium, supplemented with 0.2 mg/l of IBA. Finally, the rooted plants were transferred to the soil with 80% success rate. This protocol was utilized for the in vitro propagation of this endangered plant species.
- Published
- 2013
- Full Text
- View/download PDF
25. Tolmie-Browne-McGettrick-Stephenson; Coat's reaction, ectodermal dysplasia, abnormal bone marrow leucodystrophy and calcification resembling intracranial bath sealant.
- Author
-
Crow, Yanick, McMenamin, J., Haenggeli, C.A., Hadley, D.M., Tirupathi, S., Treacy, E.P., Zuberi, S.M., Browne, B.H., Tolmie, J.L., and Stephenson, J.B.P.
- Subjects
GENETIC research ,RETROLENTAL fibroplasia ,CALCIFICATION ,BRAIN ,ETIOLOGY of diseases - Abstract
In 1988 we reported two sisters with bilateral exudative retinopathy of Coats' type, sparse hair, dystrophic nails and primeval splashes of intracranial calcification. We now provide an update on this family documenting the occurrence of skeletal defects comprising abnormal bone marrow, osteopenia and sclerosis with a tendency to fractures, a mixed cerebellar and extrapyramidal movement disorder, infrequent epileptic seizures, leucodystrophic changes and post-natal growth failure. Additionally, we present two previously unreported individuals from Ireland and Switzerland with the identical disorder which is characteristerised by a unique pattern and distribution of brain calcification. Since our original publication a number of other authors have described, frequently as a new' syndrome, cases with a variable combination of the same features observed in our patients. We review this literature to further characterise the Tolmie-Browne-McGettrick-Stephenson syndrome which may include pancytopenia as a major finding and encompass cases previously described by Revesz, Gouti_res, Sazgar and possibly Labrune. Tolmie-Browne-McGettrick-Stephenson syndrome is likely an autosomal recessive progressive microangiopathy. The possible phenotypic overlap with dyskeratosis congenita might provide a clue to the molecular aetiology of this multisystem disorder. [ABSTRACT FROM AUTHOR]
- Published
- 2003
26. FAST CHANNEL SYNDROME PRESENTATION, DIAGNOSIS AND MANAGEMENT IN AN INFANT
- Author
-
Mallappa, A., Tirupathi, S., Boyd, J., 'Connor, O B., and Illingworth, M.
- Published
- 2010
27. Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C
- Author
-
Petter Strømme, Ferda Ozkinay, Heike Philippi, Pontus Wasling, Sebastien Moutton, Dagmar Timmann, Maria Vázquez-López, Pedro S Pinto, Annette Bley, A. Blaschek, Gabriel Á. Martos-Moreno, A. Micheil Innes, Alan Hill, Argirios Dinopoulos, Fiona Haslam McKenzie, Janice M. Fletcher, Barbara Plecko, Hanna Mierzewska, Matthis Synofzik, Cathy A. Stevens, Raphael Schiffmann, Janina Gburek-Augustat, Miriam Nickel, Constantin Polychronakos, Kether Guerrero, Susan M. Kirwin, Icíar Cimas, Inga Harting, Bwee Tien Poll-The, Vera Popovic, Coriene E. Catsman-Berrevoets, Simona Orcesi, Nicole I. Wolf, Laura Roos, Grace M. Hobson, Norberto Rodriguez Espinosa, Gert Wiegand, Bernard Brais, Julia Rankin, Marjo S. van der Knaap, Cyril Goizet, Michelle Demos, Sandra Pekic, Ingrid Tejera-Martin, Adeline Vanderver, Stefanie Perrier, Brent L. Fogel, Eriskay Liston, Meriel McEntagart, Ferdy K. Cayami, Bart P.C. van de Warrenburg, Anne Ronan, Paolo Gasparini, Bernard Corenblum, Joost Rotteveel, Mercedes Pineda Marfa, Roberta La Piana, Richard Webster, Eugen Boltshauser, Amytice Mirchi, Dietz Rating, Klara Brozova, Ingeborg Krägeloh-Mann, Marcelo Andrés Kauffman, Nesrin Senbil, Gerhard Kluger, Brenda Banwell, Flavio Faletra, Michel Sylvain, Urania Kotzaeridou, Tahir Atik, Raymond Fernandez, Stephan Saikali, William S. Benko, Fernando I Monton, Dorota Gieruszczak-Białek, Dolores Gonzalez Moron, Charles Marques Lourenço, Amy Pizzino, Ana Potic, Elsa Rossignol, Ton J. de Grauw, William T. Gibson, Luan T. Tran, Davide Tonduti, Rosalina M. L. van Spaendonk, Rocío Sánchez-Carpintero, Raymond P J Murphy, Guillaume Sébire, Daniela Pohl, Joshua L. Bonkowsky, Christopher Clough, Sandya Tirupathi, Maria Eugenia Garcia Garcia, Christoph Hertzberg, Serge Melançon, Anjum Misbahuddin, Félixe Pelletier, Evangeline Wassmer, Gail Dolan, Marie-France Rioux, Geneviève Bernard, Sunita Venkateswaran, Steffi Patzer, Aline Hamati, Helio Pedro, Hüseyin Onay, Drago Bratkovic, Petra Kolditz, Daniel Tibussek, Sakkubai Naidu, Nicole Ulrick, Emmanouil Rampakakis, William McClintock, Anna Schossig, Mohnish Suri, Grace Yoon, László Sztriha, John R. Østergaard, Laboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) (U1211 INSERM/MRGM), Université de Bordeaux (UB)-Groupe hospitalier Pellegrin-Institut National de la Santé et de la Recherche Médicale (INSERM), Canadian Institutes of Health Research, Fonds de recherche du Québec, Fonds de Recherche du Québec - Santé, Neurology, Functional Genomics, Pelletier, F., Perrier, S., Cayami, F. K., Mirchi, A., Saikali, S., Tran, L. T., Ulrick, N., Guerrero, K., Rampakakis, E., van Spaendonk, R. M. L., Naidu, S., Pohl, D., Gibson, W. T., Demos, M., Goizet, C., Tejera-Martin, I., Potic, A., Fogel, B. L., Brais, B., Sylvain, M., Sebire, G., Lourenco, C. M., Bonkowsky, J. L., Catsman-Berrevoets, C., Pinto, P. S., Tirupathi, S., Stromme, P., de Grauw, T., Gieruszczak-Bialek, D., Krageloh-Mann, I., Mierzewska, H., Philippi, H., Rankin, J., Atik, T., Banwell, B., Benko, W. S., Blaschek, A., Bley, A., Boltshauser, E., Bratkovic, D., Brozova, K., Cimas, I., Clough, C., Corenblum, B., Dinopoulos, A., Dolan, G., Faletra, F., Fernandez, R., Fletcher, J., Garcia Garcia, M. E., Gasparini, P., Gburek-Augustat, J., Gonzalez Moron, D., Hamati, A., Harting, I., Hertzberg, C., Hill, A., Hobson, G. M., Innes, A. M., Kauffman, M., Kirwin, S. M., Kluger, G., Kolditz, P., Kotzaeridou, U., La Piana, R., Liston, E., Mcclintock, W., Mcentagart, M., Mckenzie, F., Melancon, S., Misbahuddin, A., Suri, M., Monton, F. I., Moutton, S., Murphy, R. P. J., Nickel, M., Onay, H., Orcesi, S., Ozkinay, F., Patzer, S., Pedro, H., Pekic, S., Pineda Marfa, M., Pizzino, A., Plecko, B., Poll-The, B. T., Popovic, V., Rating, D., Rioux, M. -F., Rodriguez Espinosa, N., Ronan, A., Ostergaard, J. R., Rossignol, E., Sanchez-Carpintero, R., Schossig, A., Senbil, N., Sonderberg Roos, L. K., Stevens, C. A., Synofzik, M., Sztriha, L., Tibussek, D., Timmann, D., Tonduti, D., van de Warrenburg, B. P., Vazquez-Lopez, M., Venkateswaran, S., Wasling, P., Wassmer, E., Webster, R. I., Wiegand, G., Yoon, G., Rotteveel, J., Schiffmann, R., van der Knaap, M. S., Vanderver, A., Martos-Moreno, G. A., Polychronakos, C., Wolf, N. I., Bernard, G., Human genetics, Pediatric surgery, Amsterdam Reproduction & Development (AR&D), and Amsterdam Neuroscience - Cellular & Molecular Mechanisms
- Subjects
Male ,Recessive Mutations ,Mitochondrial Diseases ,genetics [Mitochondrial Diseases] ,hypomyelination ,etiology [Endocrine System Diseases] ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Medizin ,POLR3A protein, human ,genetics [Endocrine System Diseases] ,Biochemistry ,Cohort Studies ,0302 clinical medicine ,Endocrinology ,etiology [Growth Disorders] ,Diagnosis ,epidemiology [Growth Disorders] ,4H leukodystrophy ,Online Only articles ,Child ,Prospective cohort study ,Growth Disorders ,genetics [Growth Disorders] ,POLR3-related leukodystrophy ,0303 health sciences ,DNA-Directed RNA Polymerases ,Pattern-Recognition ,Diffuse Hypomyelination ,Classification ,Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3] ,3. Good health ,epidemiology [Hereditary Central Nervous System Demyelinating Diseases] ,Hormone Deficiency ,POLR1C protein, human ,Child, Preschool ,Female ,medicine.symptom ,AcademicSubjects/MED00250 ,Adult ,Delayed puberty ,Subunit ,medicine.medical_specialty ,Adolescent ,Context (language use) ,Endocrine System Diseases ,Short stature ,genetics [Hereditary Central Nervous System Demyelinating Diseases] ,Genetic Heterogeneity ,Young Adult ,03 medical and health sciences ,SDG 3 - Good Health and Well-being ,hypogonadotropic hypogonadism ,Hypogonadotropic hypogonadism ,etiology [Hypogonadism] ,Internal medicine ,medicine ,genetics [RNA Polymerase III] ,Humans ,Endocrine system ,ddc:610 ,POLR3B protein, human ,genetics [DNA-Directed RNA Polymerases] ,Clinical Research Articles ,Retrospective Studies ,030304 developmental biology ,complications [Hereditary Central Nervous System Demyelinating Diseases] ,business.industry ,Hypogonadism ,Biochemistry (medical) ,Leukodystrophy ,Infant, Newborn ,Infant ,RNA Polymerase III ,medicine.disease ,complications [Mitochondrial Diseases] ,epidemiology [Mitochondrial Diseases] ,epidemiology [Endocrine System Diseases] ,Hereditary Central Nervous System Demyelinating Diseases ,Cross-Sectional Studies ,Biological Variation, Population ,Mutation ,epidemiology [Hypogonadism] ,business ,030217 neurology & neurosurgery ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,Hormone - Abstract
Context 4H or POLR3-related leukodystrophy is an autosomal recessive disorder typically characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism, caused by biallelic pathogenic variants in POLR3A, POLR3B, POLR1C, and POLR3K. The endocrine and growth abnormalities associated with this disorder have not been thoroughly investigated to date. Objective To systematically characterize endocrine abnormalities of patients with 4H leukodystrophy. Design An international cross-sectional study was performed on 150 patients with genetically confirmed 4H leukodystrophy between 2015 and 2016. Endocrine and growth abnormalities were evaluated, and neurological and other non-neurological features were reviewed. Potential genotype/phenotype associations were also investigated. Setting This was a multicenter retrospective study using information collected from 3 predominant centers. Patients A total of 150 patients with 4H leukodystrophy and pathogenic variants in POLR3A, POLR3B, or POLR1C were included. Main Outcome Measures Variables used to evaluate endocrine and growth abnormalities included pubertal history, hormone levels (estradiol, testosterone, stimulated LH and FSH, stimulated GH, IGF-I, prolactin, ACTH, cortisol, TSH, and T4), and height and head circumference charts. Results The most common endocrine abnormalities were delayed puberty (57/74; 77% overall, 64% in males, 89% in females) and short stature (57/93; 61%), when evaluated according to physician assessment. Abnormal thyroid function was reported in 22% (13/59) of patients. Conclusions Our results confirm pubertal abnormalities and short stature are the most common endocrine features seen in 4H leukodystrophy. However, we noted that endocrine abnormalities are typically underinvestigated in this patient population. A prospective study is required to formulate evidence-based recommendations for management of the endocrine manifestations of this disorder., Canadian Institutes of Health Research [201610PJT-377869, MOP-G2-341146-159133-BRIDG]; Fondation Les Amis d'Elliot; Leuco-Action; Fondation Lueur d'Espoir pour Ayden; Fondation le Tout pour Loo; Reseau de Medecine Genetique Appliquee of the Fonds de Recherche du Quebec-Sante; Compute Canada; Fonds de Recherche du Quebec en Sante (FRQS) Doctoral Scholarship; Fondation du Grand defi Pierre Lavoie Doctoral Scholarship; McGill Faculty of Medicine F. S.B. Miller Fellowship; Research Institute of the McGill University Health Centre Desjardins Studentship in Child Health Research; Directorate of Higher Education Overseas Scholarship-Dikti Scholarship, Ministry of National Education, Republic of Indonesia; CIHR [201603PJT-148695]; BC Children's Hospital Foundation through its intramural Investigator Grant Award Program (IGAP); National Institute for Neurological Disorders and Stroke [R01NS082094]; Jakob Kamens Chair in Translational Neurotherapeutics; Fonds de Recherche du Quebec-Sante (FRQS); Canadian Institutes of Health Research; European Reference Network for Rare Neurological Disorders (ERN-RND) [739510], This study was supported by grants from the Canadian Institutes of Health Research (201610PJT-377869, MOP-G2-341146-159133-BRIDG), Fondation Les Amis d'Elliot, Leuco-Action, Fondation Lueur d'Espoir pour Ayden, Fondation le Tout pour Loo, and Reseau de Medecine Genetique Appliquee of the Fonds de Recherche du Quebec-Sante to G. Bernard. This research was enabled in part by support provided by Compute Canada (www.computecanada.ca).S.Perrier is supported by the Fonds de Recherche du Quebec en Sante (FRQS) Doctoral Scholarship, the Fondation du Grand defi Pierre Lavoie Doctoral Scholarship, the McGill Faculty of Medicine F. S.B. Miller Fellowship, and the Research Institute of the McGill University Health Centre Desjardins Studentship in Child Health Research. F. K.C. is a recipient of the Directorate of Higher Education Overseas Scholarship-Dikti Scholarship, Ministry of National Education, Republic of Indonesia. W.T. G. received funding from the CIHR (201603PJT-148695) and is supported by the BC Children's Hospital Foundation through its intramural Investigator Grant Award Program (IGAP). B.L. F. was supported by the National Institute for Neurological Disorders and Stroke (R01NS082094). A.V. receives funding from the Jakob Kamens Chair in Translational Neurotherapeutics. G. Bernard has received a Research Scholar Junior 1 award from the Fonds de Recherche du Quebec-Sante (FRQS) (2012-2016) and the New Investigator Salary Award from the Canadian Institutes of Health Research (2017-2022). I.K.M., M. Synofzik, D. Tonduti, B.P.v.d.W., M.S. V.d.K., and N.I.W. are members of the European Reference Network for Rare Neurological Disorders (ERN-RND), project ID 739510.
- Published
- 2021
- Full Text
- View/download PDF
28. Thaumaturgical Distraction as a Modality for Reducing Dental Anxiety in Children: A Systematic Review.
- Author
-
Lekhwani P, Tirupathi S, and Afnan L
- Abstract
Background: Dental fear and anxiety have become a major obstacle for children to accept dental treatment. Dental anxiety ranks fifth among common fears., Aim: The aim of this current systematic review is to assess the effect of thaumaturgical distraction in reducing anxiety in children undergoing dental procedures., Materials and Methods: This current systematic review was registered in Prospero (CRD42023411750) following PRISMA guidelines. Electronic searches were performed in the databases: PubMed, Scopus, Web of Science, and Google Scholar. The search was conducted from inception to March 1, 2024. A broader search strategy was used to prevent missing articles. The search was performed using broad terminology: ((thaumaturgy) OR (magic)) AND (dental). ResearchGate was also consulted, and cross-references were reviewed on this topic to extract all available literature. Only randomized controlled trials are included for data synthesis. Narrative and systematic literature reviews are excluded. Evaluation of the risk of bias is planned using the ROB2 criteria of the Cochrane Collaboration., Results: A total of 798 titles were screened by title and abstract rigorously by three independent evaluators. After duplicate exclusion and removal of irrelevant titles, 11 articles were included for full-text analysis, of which 6 qualified for final data synthesis., Conclusion: Within the limits of the available studies, significantly lower anxiety is exhibited in the children treated under the thaumaturgical distraction group as opposed to the control group., How to Cite This Article: Lekhwani P, Tirupathi S, Afnan L. Thaumaturgical Distraction as a Modality for Reducing Dental Anxiety in Children: A Systematic Review. Int J Clin Pediatr Dent 2024;17(11):1296-1301., Competing Interests: Source of support: Nil Conflict of interest: NoneConflict of interest: None, (Copyright © 2024; The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
29. Comparative anti-plaque and anti-gingivitis efficiency of Triphala versus chlorhexidine mouthwashes in children: a systematic review and meta-analysis.
- Author
-
Minervini G, Marrapodi MM, Tirupathi S, Afnan L, Di Blasio M, Cervino G, Isola G, and Cicciù M
- Subjects
- Child, Humans, Anti-Infective Agents, Local administration & dosage, Dental Plaque Index, Periodontal Index, Chlorhexidine administration & dosage, Dental Plaque prevention & control, Gingivitis diagnosis, Gingivitis drug therapy, Gingivitis prevention & control, Mouthwashes administration & dosage, Plant Extracts administration & dosage
- Abstract
The aim of this systematic review is to comparatively evaluate the Triphala and chlorhexidine mouthwashes efficacies in decreasing plaque formation and gingivitis in children. With a priori-set inclusion and exclusion criteria's and relevant MeSH terms, the PubMed, Cochrane and Ovid SP were scrutinized from the year 1980 to April 2023 for prospective articles. Outcomes evaluated were plaque formation and gingivitis through Plaque index and Gingival index. Five studies were finally included and were analyzed qualitatively and quantitatively. Meta-analysis, was performed using a random effects model. Plaque index (PI) and Gingival Index (GI). There was no significant difference between reduction in the gingivitis and plaque accumulation between Triphala and chlorhexidine mouthwash groups in children ( p value 0.83, 0.96)., Competing Interests: The authors declare no conflict of interest., (©2024 The Author(s). Published by MRE Press.)
- Published
- 2024
- Full Text
- View/download PDF
30. Compound Odontoma Associated with Multiple Odontogenic Abnormalities in the Mandible of a Child: A Case Report and Review of Literature.
- Author
-
Budia S, Rathi N, Patil L, Tirupathi S, Singh R, Patil V, Mulla H, and Sachdev M
- Abstract
Odontomas have been described as a dental abnormality that develops due to the overgrowth of certain components of the dental lamina, which eventually leads to the formation of a poorly structured calcified mass. The occurrence has been attributed to local trauma, infection, congenital defects, odontoblastic hyperactivity, or changes in the genetic material. Clinically, odontomas are largely asymptomatic and are diagnosed during routine examinations and procedures. However, they might frequently be associated with delayed eruption, impacted teeth, or missing teeth, warranting early diagnosis and management. This current paper describes the localization and management of a compound odontoma associated with multiple odontogenic abnormalities diagnosed in a 10-year-old girl. Eventually, surgical excision was planned and performed, and the defect was packed with PRF to promote healing and regeneration of the large defect., How to Cite This Article: Budia S, Rathi N, Patil L, et al. Compound Odontoma Associated with Multiple Odontogenic Abnormalities in the Mandible of a Child: A Case Report and Review of Literature. Int J Clin Pediatr Dent 2024;17(8):945-950., Competing Interests: Source of support: Nil Conflict of interest: None Patient consent statement: The author(s) have obtained written informed consent from the patient’s parents/legal guardians for publication of the case report details and related images.Conflict of interest: None, (Copyright © 2024; The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
31. Comparative Clinical and Radiographic Success Rate of Bioceramic Premix vs Biosilicate-based Medicament as Indirect Pulp Treatment Materials in Primary Molars: A Double-blind Randomized Trial with a Follow-up of 12 Months.
- Author
-
Kothari P, Mathur A, Tirupathi S, Chauhan R, Nankar M, and Suvarna A
- Abstract
Aim: To evaluate and compare the clinical and radiographic success of NeoPUTTY® and Biodentine™ as indirect pulp treatment (IPT) materials in primary molars., Materials and Methods: This clinical trial was conducted on children aged 5-9 years. Class I carious lesions in primary molars indicated for IPT were divided into two groups-group I, NeoPUTTY®, and group II, Biodentine™. IPC was performed as per the standard protocols. The treated teeth were evaluated for clinical and radiographic success, along with the presence of a dentinal bridge at 6 and 12 months, by three blind examiners independently. All the data were tabulated, and statistical analysis was performed using the Mann-Whitney U test., Results: Interexaminer reliability was analyzed using Fleiss κ statistics, and it showed "good" agreement. Clinical success was 100% in both groups at 6- and 12-month follow-up, while radiographic success was also 100% at 6-month follow-up for both groups. However, at 12-month follow-up, it was 93.33% for group I and 100% for group II. The difference was statistically nonsignificant. The presence of a dentinal bridge at 12-month follow-up was seen in 86.66% of cases in group I and 100% of cases in group II, but there was no statistical difference observed between them with a p -value of 0.555., Conclusion: Within the limitations of the study, we conclude that NeoPUTTY® and Biodentine™ are equally effective as IPT agents in primary teeth., How to Cite This Article: Kothari P, Mathur A, Tirupathi S, et al. Comparative Clinical and Radiographic Success Rate of Bioceramic Premix vs Biosilicate-based Medicament as Indirect Pulp Treatment Materials in Primary Molars: A Double-blind Randomized Trial with a Follow-up of 12 Months. Int J Clin Pediatr Dent 2024;17(7):748-753., Competing Interests: Source of support: Nil Conflict of interest: NoneConflict of interest: None, (Copyright © 2024; The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
32. Factors Influencing the Fit and Retention of Computer-aided Design/Computer-aided Manufacturing-based Three-dimensional Printed Band and Loop Space Maintainers.
- Author
-
Tirupathi S and Rathi N
- Abstract
Three-dimensional (3D) scanning and printing in the field of pediatric dentistry is an augmented reality that has several clinical implications and advantages. The aim of this current short communication and technical note is to discuss the possibility of various shortcomings of the current intraoral scanning and 3D printing and the various limitations a clinician can face., How to Cite This Article: Tirupathi S, Rathi N. Factors Influencing the Fit and Retention of Computer-aided Design/Computer-aided Manufacturing-based Three-dimensional Printed Band and Loop Space Maintainers. Int J Clin Pediatr Dent 2024;17(6):734-735., Competing Interests: Source of support: Nil Conflict of interest: NoneConflict of interest: None, (Copyright © 2024; The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
33. Perioperative Lignocaine Intravenous Infusion (PLIV) in Maxillofacial Surgeries: Risk and Safety Considerations and Management.
- Author
-
Tirupathi S, Afnan L, and Sachdev M
- Abstract
Competing Interests: Conflict of interestNil.
- Published
- 2024
- Full Text
- View/download PDF
34. Comparative Evaluation of the Antimicrobial Efficacy of Elettaria cardamomum (0.5%) Mouthwash, Camellia sinensis (0.5%) Mouthwash, and 0.12% Chlorhexidine Gluconate Mouthwash against Streptococcus mutans: An In Vitro Study.
- Author
-
Deolikar S, Jawdekar A, Saraf T, Thribhuvanan L, and Tirupathi S
- Abstract
Aim: The in vitro study aimed to evaluate and compare the antimicrobial efficacy of Elettaria cardamomum (0.5%) mouthwash, Camellia sinensis (0.5%) mouthwash, and 0.12% chlorhexidine gluconate mouthwash against Streptococcus mutans., Materials and Methods: A total of 60 samples of the five mouthwash preparations were prepared to check for their antimicrobial efficacy. The zone of inhibition (ZOI) against S. mutans was measured as a diameter in mm, and the minimum inhibitory concentration (MIC) of mouthwash preparations was measured as μg/mL. All the groups were compared statistically using the Mann-Whitney U test and the Kruskal-Wallis test., Results: The highest ZOI was observed in group V chlorhexidine gluconate [mean: 20.8, standard deviation (SD): 0.58], followed by group III C. sinensis (alcohol-free) (mean: 15.5, SD: 0.67), group IV C. sinensis (alcohol-based) (mean: 14.08, SD: 0.66), and group II E. cardamomum (alcohol-based) (mean: 13.2, SD: 0.45). The least ZOI was observed in group I E. cardamomum (alcohol-free) (mean: 10.7, SD: 0.45). This difference was statistically significant ( p < 0.01). The MIC was similar in all the groups ( p = 0.13)., Conclusion: Chlorhexidine gluconate 0.12% mouthwash showed the best antimicrobial action; however, C. sinensis mouthwash showed potential against S. mutans. E. cardamomum mouthwash exhibited limited antimicrobial activity., How to Cite This Article: Deolikar S, Jawdekar A, Saraf T, et al. Comparative Evaluation of the Antimicrobial Efficacy of Elettaria cardamomum (0.5%) Mouthwash, Camellia sinensis (0.5%) Mouthwash, and 0.12% Chlorhexidine Gluconate Mouthwash against Streptococcus mutans: An In Vitro Study. Int J Clin Pediatr Dent 2024;17(4):461-466., Competing Interests: Source of support: Nil Conflict of interest: NoneConflict of interest: None, (Copyright © 2024; The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
35. Quantum dots in noninvasive imaging of oral squamous cell carcinomas: A scoping literature review.
- Author
-
Shetty B, Chauhan RS, Tirupathi S, Krishnapriya N, Patil L, and Rathi N
- Subjects
- Humans, Optical Imaging methods, Quantum Dots chemistry, Mouth Neoplasms diagnostic imaging, Mouth Neoplasms diagnosis, Mouth Neoplasms pathology, Carcinoma, Squamous Cell diagnostic imaging, Carcinoma, Squamous Cell diagnosis, Carcinoma, Squamous Cell pathology
- Abstract
Abstract: The current scoping review's objective was to outline existing applications, recent breakthroughs, and quantum dots' applicability in imaging of oral squamous cell cancer. Quantum dots are nanometric semiconductor crystals with customizable optical characteristics and intense, stable fluorescence suited for bioimaging and labeling. We used the Preferred reporting items for systematic reviews and meta-analyses (PRISMA) recommendations for conducting our systematic search. An analysis of the properties and applications of quantum dots in noninvasive detection of oral squamous cell cancer is presented in this study, which comprehensively explores the available evidence. Following searches in the databases PubMed, Ovid SP, and Cochrane using the search terms quantum dots AND oral squamous cell cancer, 55 published publications were chosen for this review. The review identified a total of eight papers that met the criteria. In noninvasive detection of oral squamous cell carcinoma, quantum dots have the potential to offer an array of therapeutic and diagnostic applications. Furthermore, quantum dots emit near-infrared and visible light, which is advantageous in biological imaging since it reduces light dispersion and absorption of tissue. The future may see quantum dots become a popular noninvasive imaging technique for oral squamous cell cancer. The number of studies accessible is quite limited, and further research is required., (Copyright © 2023 Copyright: © 2023 Journal of Cancer Research and Therapeutics.)
- Published
- 2024
- Full Text
- View/download PDF
36. Guidance of Erupting First Permanent Molar in Complex Clinical Scenarios: A Case Series.
- Author
-
Gunjal PY, Chauhan RS, Tirupathi S, Budia S, and Kothari P
- Abstract
Aim: The aim of this current case series is to propose various design modifications of the conventional distal shoe space maintainers in relation to complex clinical scenarios., Background: Primary dentition plays a significant role in preserving space for underlying unerupted permanent teeth; early childhood caries (ECC) is a serious public health problem in both developing and developed countries, and it is often left untreated. Its consequences can have an immediate and long-term impact on the child's quality of life and overall health. Premature loss of primary dentition can result in loss of arch length, thereby hampering the eruption of the succeedaneous tooth, which can further lead to malalignment, crowding, rotation, and impaction of the permanent teeth. Space maintainers are advocated in cases where extraction of primary molars is inevitable. In the early loss of the second primary molar, a distal-shoe space maintainer is advocated to guide the eruption, as well as prevent mesial migration of the first permanent molar (FPM) during the eruption. In clinical scenarios where multiple losses of deciduous molars occur bilaterally, obtaining adequate anchorage is questionable and futile. The following clinical modifications, however, are useful in overcoming the problems related to the same. The following case series intends to project various modifications of distal shoes in complex scenarios., Case Description: Various modifications of the distal shoe have been proposed in our current case series. The appliances were adjusted individually on a case-to-case basis depending on the clinical scenario. A 1-year clinical follow-up was carried out on all the patients., Conclusion: All the clinical modifications were successful in guiding the eruption of a FPM; there were no complications during any follow-up visit., Clinical Significance: In cases where the traditional design is not indicated, certain modifications in distal shoes by adding new components to the appliance will allow the appliance to be placed and the space to be maintained effectively. Along with this, reinforcement of parents and the child for oral hygiene maintenance will maintain the remaining healthy tooth structure and increase the success of treatment., How to Cite This Article: Gunjal PY, Chauhan RS, Tirupathi S, et al. Guidance of Erupting First Permanent Molar in Complex Clinical Scenarios: A Case Series. Int J Clin Pediatr Dent 2024;17(3):362-367., Competing Interests: Source of support: Nil Conflict of interest: NoneConflict of interest: None, (Copyright © 2024; The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
37. Prevalence of temporomandibular disorders in juvenile idiopathic arthritis evaluated with diagnostic criteria for temporomandibular disorders: A systematic review with meta-analysis.
- Author
-
Ronsivalle V, Marrapodi MM, Tirupathi S, Afnan L, Cicciù M, and Minervini G
- Subjects
- Humans, Prevalence, Child, Adolescent, Temporomandibular Joint Disorders epidemiology, Temporomandibular Joint Disorders diagnosis, Arthritis, Juvenile complications, Arthritis, Juvenile epidemiology, Arthritis, Juvenile diagnosis
- Abstract
Background: Juvenile idiopathic arthritis (JIA) is a very common systemic inflammatory rheumatic disorder affecting the musculoskeletal system in children below 16 years of age. Joint inflammation and tissue destruction is the prime characteristic of the disease. Along with the systemic involvement in the long joints, several studies are mentioning the increased association of temporomandibular disorders (TMDs) in JIA. This current systematic review intends to find the prevalence rate of TMD in JIA-affected individuals as compared to healthy controls., Methods: We have searched in PubMed, Scopus and Ovid SP for articles published between the timeframe 1 January 1990 and 1 June 2023. All the searched articles were subjected to the Population, Exposure, Comparison, and Outcome model (PECO) based on which inclusion or exclusion is carried out. Participants (P) are children below 18 years of age, Exposure (E) is children or adolescents with a diagnosis of JIA, Comparator is age and gender-matched healthy controls who has no JIA or any systemic disorder, Outcome (O) is the prevalence of TMD. Only the studies that evaluated TMD using diagnostic criteria for evaluation of TMD (DC/TMD) were included in the analysis. We have set the exclusion to the following reasons- diagnostic sensitivity studies, case reports, and systematic reviews. The software Review Manager Version 5.4 (Cochrane Collaboration) was used to perform the pooled analysis. We measured the risk ratio (RR) between the two groups (JIA and no JIA) for the outcome TMD., Results: The pooled total included subjects were 366 in this review with an established diagnosis of JIA as evaluated by DC/TMD. The overall effect of the pooled data suggests that there is a significant difference in the TMD prevalence in the JIA group when compared to the control, results suggest that TMD is more prevalent in the JIA group RR 3.86; 95% CI [2.59, 5.76]., Conclusion: Overall, based on the data we can suggest a positive relationship between JIA and TMD, hence presence of JIA can be a risk factor for the development of TMD. The sensitivity of DC/TMD is low when compared to magnetic resonance imaging., (© 2023 The Authors. Journal of Oral Rehabilitation published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
38. Comparative Spectrophotometric Assessment of Color Stability of Two Hybrid Composite Materials in an Oral Environment when Exposed to Various Liquids.
- Author
-
Thribhuvanan L, Saravanakumar MS, Gopalakrishnan A, Tirupathi S, and Deolikar S
- Abstract
Introduction: The primary intent of this scientific research is to effectively assess and collate the inherent potentiality of the two selected investigative composite materials in effectual maintenance of their standard color following subsequent and consistent submersion in customary available pediatric liquids consumed by children. The above investigation will be effectively estimated using the Commission Internationale de I'Eclairege (CIE) L*a*b* system-based spectrophotometer., Materials and Methods: A total of 100 composites of spheroidal plates were fabricated accordingly. A total of 50 nanohybrids and microhybrids of 8 × 2 mm were fabricated and timely cured using a light cure unit for an approximated time period of 40 seconds. This was then trialled by subsequent sample submersion in the specified five immersive media, which include mineral water, tea, Mirinda, pomegranate juice, and iron syrup, respectively, for a definitive and habitual time of thrice daily up to 15 minutes for a duration of 28 experimental days. The respective marked readings were recorded on the 7th, 14th, 21st, and 28th days by utilization of a CIE L*a*b* system-based spectrophotometer., Results: Mann-Whitney U test and Friedman's Test were utilized for statistical evaluation of the above-described experimental research. The p -value was statistically found to be significant at ( p < 0.001)., Conclusion: The conclusive findings from the above-defined experimental research were that iron syrup was found to cause the most noticeable and definitive staining in comparison to other immersive media. Nanohybrid composite restorative material was hence identified as being highly resistant to staining and possessing an undeniable ability to maintain the persistent color, unlike its microhybrid counterpart., Clinical Significance: The esthetic appearance is an important factor for both the parents and children; hence, this determines that the longevity of color stability of restorative materials is of valid significance., How to Cite This Article: Thribhuvanan L, MS S, Gopalakrishnan A, et al. Comparative Spectrophotometric Assessment of Color Stability of Two Hybrid Composite Materials in an Oral Environment when Exposed to Various Liquids. Int J Clin Pediatr Dent 2024;17(2):176-183., Competing Interests: Source of support: Nil Conflict of interest: None, (Copyright © 2024; The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
39. Is trigeminal neuralgia the tip of cancer iceberg: An insight.
- Author
-
Tirupathi S and Afnan L
- Subjects
- Humans, Trigeminal Neuralgia diagnosis, Trigeminal Neuralgia etiology, Neoplasms
- Published
- 2024
- Full Text
- View/download PDF
40. Comparison of Skeletal Changes in the Temporomandibular Joint between the Twin Block Appliance and Fixed Functional Appliance: A Longitudinal Follow-up Study.
- Author
-
Halapanavar B, Padmini MN, Deshmukh S, Tirupathi S, Waremani AS, and Kasodekar A
- Abstract
Aim: This current study evaluated and compared the skeletal changes in the head of the condyle, glenoid fossa, and articular space between the twin block appliance and PowerScope™ a fixed functional appliance., Materials and Methods: This study was a pilot, randomized, single-blinded, assessing the skeletal changes in the components of the temporomandibular joint (TMJ) using cone-beam computed tomography (CBCT). The study was conducted in 20 subjects in the age range of 11-14 years with class II division 1 malocclusion. These subjects were distributed randomly between two groups with an allocation ratio of 1:1 (group I-twin block and group I-PowerScope™). Follow-ups of both groups were done till desirable skeletal correction was attained (clinical edge-to-edge incisor relation)., Results: Condylar parameters such as position, height, and length were evaluated bilaterally in the CBCT scans. After using both devices, there was an increase in all condylar qualities; however, the twin block appliance showed a more noticeable difference, which has been determined to be statistically significant. In the twin block group, there was an average decrease of 0.56 mm in the anterior articular space and an increase of 1.2 and 2.64 mm in the middle and posterior articular spaces, respectively. In the PowerScope™ group, there was an average decrease of 0.23 mm in the anterior articular space and an increase of 2.55 and 1.85 mm in the middle and posterior articular spaces, respectively. In the case of the twin block device, the change in glenoid fossa angle was observed to be 6.1 mm on both sides and a mean difference of 1.25 mm on the right-side and 1.75 mm on the left-side was observed in the case of PowerScope™. The difference was established to be significant with a p < 0.05 in all cases., Conclusion: Condylar attributes increased after the application of both devices but the difference was more pronounced in the case of twin block appliances. The difference in articular space (middle and posterior) between the twin block group and PowerScope™ group, was not significant statistically. In the present study, the remodeling in the glenoid fossa was greater in the twin block group compared to the PowerScope™ group., How to Cite This Article: Halapanavar B, MN P, Deshmukh S, et al. Comparison of Skeletal Changes in the Temporomandibular Joint between the Twin Block Appliance and Fixed Functional Appliance: A Longitudinal Follow-up Study. Int J Clin Pediatr Dent 2024;17(1):7-14., Competing Interests: Source of support: Nil Conflict of interest: None, (Copyright © 2024; The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
41. Efficacy and safety of onasemnogene abeparvovec in children with spinal muscular atrophy type 1: real-world evidence from 6 infusion centres in the United Kingdom.
- Author
-
Gowda V, Atherton M, Murugan A, Servais L, Sheehan J, Standing E, Manzur A, Scoto M, Baranello G, Munot P, McCullagh G, Willis T, Tirupathi S, Horrocks I, Dhawan A, Eyre M, Vanegas M, Fernandez-Garcia MA, Wolfe A, Pinches L, Illingworth M, Main M, Abbott L, Smith H, Milton E, D'Urso S, Vijayakumar K, Marco SS, Warner S, Reading E, Douglas I, Muntoni F, Ong M, Majumdar A, Hughes I, Jungbluth H, and Wraige E
- Abstract
Background: Real-world data on the efficacy and safety of onasemnogene abeparvovec (OA) in spinal muscular atrophy (SMA) are needed, especially to overcome uncertainties around its use in older and heavier children. This study evaluated the efficacy and safety of OA in patients with SMA type 1 in the UK, including patients ≥2 years old and weighing ≥13.5 kg., Methods: This observational cohort study used data from patients with genetically confirmed SMA type 1 treated with OA between May 2021 and January 2023, at 6 infusion centres in the United Kingdom. Functional outcomes were assessed using age-appropriate functional scales. Safety analyses included review of liver function, platelet count, cardiac assessments, and steroid requirements., Findings: Ninety-nine patients (45 SMA therapy-naïve) were treated with OA (median age at infusion: 10 [range, 0.6-89] months; median weight: 7.86 [range, 3.2-20.2] kg; duration of follow-up: 3-22 months). After OA infusion, mean ± SD change in CHOP-INTEND score was 11.0 ± 10.3 with increased score in 66/78 patients (84.6%); patients aged <6 months had a 13.9 points higher gain in CHOP-INTEND score than patients ≥2 years (95% CI, 6.8-21.0; P < 0.001). Asymptomatic thrombocytopenia (71/99 patients; 71.7%), asymptomatic troponin-I elevation (30/89 patients; 33.7%) and transaminitis (87/99 patients; 87.9%) were reported. No thrombotic microangiopathy was observed. Median steroid treatment duration was 97 (range, 28-548) days with dose doubled in 35/99 patients (35.4%). There were 22.5-fold increased odds of having a transaminase peak >100 U/L (95% CI, 2.3-223.7; P = 0.008) and 21.2-fold increased odds of steroid doubling, as per treatment protocol (95% CI, 2.2-209.2; P = 0.009) in patients weighing ≥13.5 kg versus <8.5 kg. Weight at infusion was positively correlated with steroid treatment duration (r = 0.43; P < 0.001). Worsening transaminitis, despite doubling of oral prednisolone, led to treatment with intravenous methylprednisolone in 5 children. Steroid-sparing immunosuppressants were used in 5 children to enable steroid weaning. Two deaths apparently unrelated to OA were reported., Interpretation: OA led to functional improvements and was well tolerated with no persistent clinical complications, including in older and heavier patients., Funding: Novartis Innovative Therapies AG provided a grant for independent medical writing services., Competing Interests: Vasantha Gowda has participated in scientific advisory boards, scientific symposia and teaching initiatives for Biogen, Roche, Novartis, Wave Life Sciences, PTC therapeutics and Pfizer, received honoraria from Neurology Academy, Roche, Novartis and has been involved as principal investigator with PTC therapeutics, Wave Life Sciences and Catabasis. Mark Atherton has received conference sponsorship from Novartis. Jennie Sheehan has participated in advisory boards for Roche, received conference sponsorships from Roche and Biogen and honoraria from Novartis. Mariacristina Scoto has been involved as principal investigator in clinical trials from Roche, Biogen and Novartis and has participated in Scientific Advisory boards and teaching initiatives for Roche, Novartis and Biogen. Giovanni Baranello has been involved as principal investigator of clinical trials sponsored by Roche, Novartis, Sarepta, Pfizer, NS Pharma, Reveragen, Scholar Rock, and has received speaker and/or consulting fees from Sarepta, PTC Therapeutics, Pfizer, Biogen, Novartis Gene Therapies, Inc. (AveXis), and Roche, and grants from Sarepta, Roche and Novartis Gene Therapies. Archana Murugan has received conference sponsorship from Roche. Anil Dhawan has participated in advisory boards for Novartis, BitBio, Aspect Bio, Astellas. Michael Eyre is supported by Action Medical Research and the British Paediatric Neurology Association. Laurent Servais reports participation in advisory boards and scientific symposia from Biogen, Roche, Novartis, Scholar Rock and BioHaven and grants from the aforementioned and Zentech, Perkin Almers. Francesco Muntoni reports participation in advisory boards and scientific symposia from Biogen, Roche and Novartis and funding from Biogen and Roche for the SMA REACH National database. Min Ong has participated in advisory boards for Biogen, Novartis, Roche & CSL Behring and has received conference sponsorship from Roche and speaker fees from Biogen, and honorarium from Neurology Academy. Imelda Hughes has received honoraria from Santhera, Roche, PTC Therapeutics, Sarepta, Biogen and Novartis, conference sponsorships from PTC Therapeutics, Novartis and Biogen. Heinz Jungbluth has participated in advisory board activities for Pfizer, Astellas, Audentes and Armgo. Elizabeth Wraige has undertaken consultancy work for Novartis. Maria Vanegas has received conference sponsorship from Novartis and meeting sponsorship from SMA Europe. Sandya Tirupathi has received conference sponsorships from Novartis and PTC. Marjorie Illingworth has received conference sponsorships from Roche and Biogen. Adnan Manzur received honorarium and meeting sponsorship from Pi Healthcare. Sarah D’Urso has received conference sponsorship from Biogen. Tracey Willis has received honorarium and conference sponsorship from Novartis. Sinead Warner has received conference sponsorship from Novartis and consultancy fees from Roche. No other disclosures were reported., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
42. Prevalence of temporomandibular disorders (TMD) in bleeding disorders: A systematic review with meta-analysis.
- Author
-
Minervini G, Marrapodi MM, Tirupathi S, Afnan L, Ronsivalle V, Cervino G, and Cicciù M
- Subjects
- Child, Adult, Adolescent, Humans, Child, Preschool, Young Adult, Middle Aged, Prevalence, Temporomandibular Joint, Hemophilia A complications, Hemophilia A epidemiology, Temporomandibular Joint Disorders complications
- Abstract
Background: Haemophilia A, B and von Willebrand disease are the most common bleeding disorders. There is an increased tendency of spontaneous bleeding into joints resulting in intra-articular infection. It is believed that Temporomandibular Joint (TMJ) can be affected in a similar manner which can further lead to limited mouth opening and ankylosis. The association between bleeding disorders (BD) and development of temporomandibular disorders (TMD) is poorly understood. This systematic review intends to evaluate the association of TMD in individuals with inherited bleeding disorders as compared to healthy controls., Methods: PubMed, Ovid SP and Google Scholar were searched for articles published between the times of inception to 1 May 2023. All the articles were subjected to Population, Exposure, Comparison and Outcome model (PECO) based on which inclusion and exclusion criteria were applied. Participants (P) is children, adults or adolescents; Exposure (E) is children, adults or adolescents with a diagnosis of Haemophilia or bleeding disorder (BD); Comparator (C) is age and gender-matched healthy controls who do not have Haemophilia or bleeding disorder; Outcome (O) is prevalence of any signs or symptoms (clinical, radiographic) that is suggestive of temporomandibular disorder (TMD). Studies showing the prevalence of TMD are included for qualitative analysis. Only the studies which provided data of the prevalence of TMD in both the groups (BD and healthy controls) were included in the quantitative analysis. TMD diagnosis can be by clinical signs and symptoms, radiographic criteria, Diagnostic Criteria for Temporomandibular Disorders (DC/TMD), The Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) or any other imaging criteria (MRI). We have set the exclusion criteria as articles without a control group, diagnostic sensitivity studies, case reports and systematic reviews and narrative reviews. The software Review Manager version 5.4 (Cochrane Collaboration) was used to perform the pooled analysis. We measured the risk ratio (RR) between the two groups (BD and healthy controls) for the outcome TMD., Results: A total of seven studies are included for qualitative analysis of data. The age of the population (BD and control) in the included studies ranged between 2 and 57 years. The prevalence of TMD in individual studies varied from 2% to 77%, and controls in the individual studies varied from 2% to 14%. Among the included studies, only clinical signs, symptoms and history were taken into consideration in four studies. Four studies were included for meta-analysis, the pooled result of the four studies suggests there is no significant difference in the prevalence of TMD in BD and control group (p value = .11, RR 2.19; 95% CI [0.84, 5.73])., Conclusion: This systematic review and meta-analysis elicits no association between bleeding disorders and increased prevalence of TMD., (© 2023 The Authors. Journal of Oral Rehabilitation published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
43. Three-dimensional Printed Esthetic Innovative Space Maintainer for Children with ADHD: Short Communication.
- Author
-
Rathi N, Tirupathi S, and Sawarkar S
- Abstract
This current clinical technique describes the case report regarding single-visit fabrication, three-dimensional (3D) printing, and delivery of space maintainers in two children with severe attention-deficit hyperactivity disorder., How to Cite This Article: Rathi N, Tirupathi, Sawarkar S. Three-dimensional Printed Esthetic Innovative Space Maintainer for Children with ADHD: Short Communication. Int J Clin Pediatr Dent 2023;16(6):908-910., Competing Interests: Source of support: Nil Conflict of interest: None, (Copyright © 2023; The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
44. Effectiveness of thaumaturgic distraction in alleviation of anxiety in 4-6-year-old children during inferior alveolar nerve block administration: a randomized controlled trial.
- Author
-
Kothari P, Mathur A, Chauhan RS, Nankar M, Tirupathi S, and Suvarna A
- Abstract
Background: Dental anxiety is a matter of serious concern to pediatric dentists as it may impede the efficient delivery of dental care. If not adequately resolved, a persistent negative response pattern may emerge. Thaumaturgy, commonly known as magic trick, has become popular recently. It is a tool that distracts and relaxes the child by using magic trick while the dentist performs necessary treatment. Hence, the aim of this study was to evaluate the effectiveness of Thaumaturgic aid in alleviation of anxiety in 4-6 - year-old children during administration of local anesthesia using the inferior alveolar nerve block (IANB) technique., Methods: Thirty children aged between 4-6 years with dental anxiety requiring IANB were included in this study. Patients were divided equally into two groups: Group I, thaumaturgic aid group and Group II, conventional non-pharmacological group using randomization. Anxiety was measured before and after using the intervention with Raghavendra Madhuri Sujata-Pictorial scale (RMS-PS), Venham's anxiety rating scale, and pulse rate. All the data were tabulated and compared using statistical analysis., Results: Children in thaumaturgy group (Group- I) exhibited significantly lower anxiety during IANB in comparison with children in the conventional group (Group- II) and the difference was statistically significant., Conclusion: Magic tricks are effective in reducing anxiety among young children during IANB; Moreover, it expands the arsenal of behavior guidance techniques for treatment of children with anxiety and plays an important role in shaping the behavior of a child in pediatric dentistry., Competing Interests: CONFLICTS OF INTEREST: The authors declare no conflict of interest., (Copyright © 2023 Journal of Dental Anesthesia and Pain Medicine.)
- Published
- 2023
- Full Text
- View/download PDF
45. Safety Considerations of Fentanyl Transdermal Patches Used for Third Molar Surgery Pain Relief.
- Author
-
Tirupathi S and Afnan L
- Abstract
Competing Interests: Conflict of interestAll authors declare that they have no conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
46. Risdiplam for the treatment of adults with spinal muscular atrophy: Experience of the Northern Ireland neuromuscular service.
- Author
-
McCluskey G, Lamb S, Mason S, NicFhirleinn G, Douglas I, Tirupathi S, Morrison KE, and McConville J
- Subjects
- Humans, Adult, Male, Female, Northern Ireland, Quality of Life, Azo Compounds, Muscular Atrophy, Spinal, Spinal Muscular Atrophies of Childhood drug therapy
- Abstract
Introduction/aims: Risdiplam is the newest available treatment for patients with spinal muscular atrophy (SMA). There is little information on its use in adults. We present the clinical experience of adults with SMA treated with risdiplam through the Early Access to Medicines Scheme (EAMS) in Northern Ireland., Methods: All adults with Type 2 SMA attending the regional neuromuscular clinic were offered risdiplam treatment. Patients had assessments of respiratory function, the Epworth Sleepiness Scale (ESS), Quality of Life Measure for People with Slowly Progressive and Genetic Neuromuscular Disease (QOLM), and Egen Klassifikation 2 (EK2) every 3 mo and the Revised Upper Limb Module for SMA (RULM) at baseline and 6 mo. All assessments other than the RULM were carried out virtually., Results: Six of seven patients who were offered risdiplam consented to treatment through the EAMS (five female, one male, mean age 33.7 y). It was generally well tolerated other than skin photosensitivity in all patients. All patients remained on therapy at 9 mo. All reported meaningful improvements in overall strength, sense of wellbeing, and speech quality. There was no change in respiratory function, daytime hypersomnolence, or upper limb function (all p > .05). There was improvement in the QOLM (p = .027) and EK2 (p = .009)., Discussion: Our study raises hopes that risdiplam may be efficacious in adults; however, more systematic studies in larger cohorts are needed before drawing any definitive conclusions. This study also demonstrated the feasibility of virtual assessments., (© 2022 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
47. Herbal topical anesthetics in dentistry: an exploratory review.
- Author
-
Tirupathi S, Gopalakrishnan D, and Deshkar S
- Abstract
Topical anesthetics are routinely used in dental practice for various purposes. They are usually available at higher dosages and have serious potential adverse reactions, such as seizures, anaphylaxis, and acquired methemoglobinemia. To date, the scope of application of herbal plants and their extracts, which have medicinal properties, has been elaborated in the field of dentistry. The growing interest in herbal medication can be attributed to the increased safety profile of herbal agents, in contrast to synthetic preparations that have a higher risk of systemic complications. Herbal preparations can induce topical anesthesia with minimal side effects. Recently, many studies have reported the use of topical herbal preparations. The current review aimed to evaluate data from various articles comparing the capacity of herbal topical anesthetic formulations and conventional synthetic anesthetics in reducing pain perception when used as local anesthesia before dental procedures., Competing Interests: DECLARATION OF INTEREST: There are no conflicts of interest to declare., (Copyright © 2022 Journal of Dental Anesthesia and Pain Medicine.)
- Published
- 2022
- Full Text
- View/download PDF
48. Comparative Fluoride Ion Release Pre and Postrecharge Situations among Three Different Pediatric Dental Restorative Materials: An In Vitro Study.
- Author
-
Mathias MR, Rathi N, Bendgude VD, Tirupathi S, Chauhan RS, Borde A, Lath T, and Shah SS
- Abstract
Objectives: To determine the initial fluoride (F) release and rerelease after recharge of three pediatric dental restorative materials when aged in artificial saliva (M1) and deionized water (M2)., Materials and Methods: A total of 30 disks, 10 disks of each restorative material R1: Jen Rainbow, Jen Dent Ukraine; R2: Tetric® N-Flow, Ivoclar Vivadent, and R3: resin-modified glass ionomer cement (RMGIC) (Fuji II LC- GC Corporation) were fabricated and were tested for F dynamics in two different media, M1: artificial saliva, M2: deionized water group. The F initial release was measured on the 1st, 7th, 14th, 21st, and 30th day, and on the 31st day, acidulated phosphate F (APF) gel was applied and F rerelease was measured on the 31st, 37th, 44th, 51st, and 60th day using F ion-specific electrode (Orion). The result was statistically analyzed using two-way analysis of variance (ANOVA) and post hoc Bonferroni test., Results: Fluoride (F) ion release was significantly higher in deionized water than in artificial saliva (M1), and F ion rerelease (after recharge) was significantly higher in artificial saliva (M1). Fuji-II LC demonstrated a significantly ( p < 0.05) higher F release and rerelease among all the tested materials. Among the tested composites, R2: Tetric® N-Flow exhibited significantly higher F dynamics than R1: Jen Rainbow composite., Conclusion: All the tested restorative materials exhibited optimum F release (0.024 ppm, that is, the range to prevent newer carious lesions) in both the pre and postrecharge conditions. Even though Fuji-II LC demonstrated significantly better F dynamics in the tested scenarios, Tetric® N-Flow has the additional advantage of improved mechanical retentive and esthetic properties along with the optimum F release in pre and postrecharge scenarios., How to Cite This Article: Mathias MR, Rathi N, Bendgude VD, et al. Comparative Fluoride Ion Release Pre and Postrecharge Situations among Three Different Pediatric Dental Restorative Materials: An In Vitro Study. Int J Clin Pediatr Dent 2022;15(6):729-735., Competing Interests: Source of support: Nil Conflict of interest: None, (Copyright © 2022; The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
49. Topical Anesthesia in Pediatric Dentistry: An Update.
- Author
-
Tirupathi S and Rajasekhar S
- Abstract
Topical anesthetics are very important tools for improving comfort in any dental procedure in children. different methods, techniques of achieving topical anesthesia are reported in the literature. The present narrative review focuses on explaining different types of topical anesthesia with a special focus on pediatric dentistry. How to cite this article: Tirupathi S, Rajasekhar S. Topical Anesthesia in Pediatric Dentistry: An Update. Int J Clin Pediatr Dent 2022;15(2):240-245., Competing Interests: Source of support: Nil Conflict of interest: None, (Copyright © 2022; The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
50. Practical Perfusion Quantification in Multispectral Endoscopic Video: Using the Minutes after ICG Administration to Assess Tissue Pathology.
- Author
-
Epperlein JP, Zayats M, Tirupathi S, Zhuk S, Tchrakian T, Mac Aonghusa P, O'Shea DF, Hardy NP, Dalli J, and Cahill RA
- Subjects
- Diagnostic Imaging, Humans, Perfusion, Fluorescent Dyes, Indocyanine Green
- Abstract
The wide availability of near infrared light sources in interventional medical imaging stacks enables non-invasive quantification of perfusion by using fluorescent dyes, typically Indocyanine Green (ICG). Due to their often leaky and chaotic vasculatures, intravenously administered ICG perfuses through cancerous tissues differently. We investigate here how a few characteristic values derived from the time series of fluorescence can be used in simple machine learning algorithms to distinguish benign lesions from cancers. These features capture the initial uptake of ICG in the colon, its peak fluorescence, and its early wash-out. By using simple, explainable algorithms we demonstrate, in clinical cases, that sensitivity (specificity) rates of over 95% (95%) for cancer classification can be achieved., (©2021 AMIA - All rights reserved.)
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.